Visit our website
New America Cypbersecurity Initiative
New America Cypbersecurity Initiative
MIT Technology Review
MIT Technology Review
io9
io9
Techdirt
Techdirt
Knowledge@Wharton
Knowledge@Wharton
Bioscience Technology
Bioscience Technology
redOrbit
redOrbit
Technology & Marketing Law Blog
Technology & Marketing Law Blog
Popular Science Blog
Popular Science Blog
Pew Research Center
Pew Research Center
Genomics Law Report
Genomics Law Report
Science 2.0
Science 2.0
The Guardian Headquarters
The Guardian Headquarters
Genetic Literacy Project
Genetic Literacy Project
Disclaimer

Statements posted on this blog represent the views of individual authors and do not necessarily represent the views of the Center for Law Science & Innovation (which does not take positions on policy issues) or of the Sandra Day O'Connor College of Law or Arizona State University.

It’s Back! The Starbucks Challenge for September 2015

Each month we feature a technology with potential legal, social and/or ethical  implications and ask:

What’s YOUR answer?

One $25 Starbucks gift card card awarded per challenge based on what we feel is the most judicious response to the highlighted technology, below. 

Deadline to be eligible for this month’s Starbucks gift card is October 1, 2015.

Smart Drugs

As happens with many drugs, they are developed to treat a particular condition and, along the way, are prescribed (or used without a prescription) to treat another.  So it is with Modafinil.  Modafinil was originally developed to treat narcolepsy until it became popular as a smart drug.  Its effectiveness in that area is supported by medical studies, but effectiveness is not the only issue.  Another is whether it is fair or acceptable, from a safety, legal or ethical perspective for people not suffering from narcolepsy or other cognitive dysfunction, to be prescribed or use cognitive enhancement drugs like Modafinil, Adderall, or Provigil.  Many have argued the practice is akin to an athlete using steroids– use of which the sporting community has condemned.  Should academic and other professional organizations follow suit in denouncing the unsupported use of smart drugs?  Why or why not?  If your answer is yes, what safeguards would you put into place?  Read more here.